Hematology Consults

Transfusion Reactions

Stop the transfusion, stabilize the patient, notify the transfusion service, and distinguish hemolysis, allergy, anaphylaxis, sepsis, circulatory overload, acute lung injury, and delayed complications.

Audience: internal medicine residents Last reviewed: July 2026

Immediate response to a suspected reaction

  1. Stop the transfusion immediately. Do not simply reduce the infusion rate.
  2. Assess airway, breathing, circulation, mental status, vital signs, oxygen saturation, and the severity of bleeding or respiratory distress.
  3. Maintain appropriate IV access according to the institution’s transfusion-reaction protocol.
  4. Recheck the patient’s identity, blood-component label, compatibility information, and bedside documentation.
  5. Notify the blood bank or transfusion service and the responsible clinician immediately.
  6. Send the component, tubing, post-reaction blood specimen, urine, cultures, or other samples as directed.
  7. Treat anaphylaxis, shock, sepsis, hemolysis, respiratory failure, or bleeding without waiting for the laboratory investigation.
Do not discard the blood bag or tubing. The transfusion service may need them for visual inspection, culture, repeat typing, or additional investigation.

Symptom-based triage

Use the presenting syndrome to narrow the differential

Fever, chills, or rigors Consider acute hemolysis, bacterial contamination, febrile nonhemolytic reaction, TRALI, or an unrelated infection.
Hypotension Consider anaphylaxis, sepsis, acute hemolysis, TRALI, severe bleeding, or a hypotensive transfusion reaction.
Dyspnea or hypoxemia Consider TACO, TRALI, anaphylaxis, acute hemolysis, sepsis, or transfusion-associated dyspnea.
Urticaria or pruritus Consider an allergic reaction, but assess carefully for airway edema, bronchospasm, or hypotension.
Back, flank, chest, or infusion-site pain Consider acute hemolysis, bacterial contamination, or another serious systemic reaction.
Dark urine or oliguria Consider intravascular hemolysis, shock, DIC, or acute kidney injury.

1. Acute transfusion reactions

Reaction Typical timing Clinical clues Immediate priorities
Acute hemolytic reaction During transfusion or shortly afterward Fever, chills, pain, hypotension, hemoglobinuria, bleeding, DIC, kidney injury, or an unexpected hemoglobin decline Stop transfusion, verify identity, notify blood bank, support circulation and urine output, investigate hemolysis, and treat shock or DIC.
Febrile nonhemolytic reaction During transfusion or within several hours Fever or chills without a more dangerous explanation Stop and evaluate first. Exclude hemolysis and bacterial contamination before labeling the reaction benign.
Mild allergic reaction Usually during transfusion or shortly afterward Isolated urticaria, pruritus, flushing, or limited rash without respiratory or cardiovascular compromise Stop the transfusion, assess for progression, notify the transfusion service, and treat according to local policy.
Anaphylaxis Often begins rapidly after a small volume Hypotension, airway edema, bronchospasm, wheezing, stridor, angioedema, generalized urticaria, or gastrointestinal symptoms Give intramuscular epinephrine promptly and manage airway, breathing, and circulation. Do not wait for blood-bank testing.
Septic reaction During transfusion or within hours High fever, rigors, hypotension, nausea, vomiting, pain, shock, or DIC Obtain patient and component cultures as directed, begin prompt broad-spectrum antimicrobial therapy, and provide sepsis care.
TACO During transfusion or within several hours Dyspnea, pulmonary edema, hypertension, tachycardia, positive fluid balance, elevated filling pressures, or response to diuresis Stop transfusion, provide oxygen or ventilatory support, position appropriately, and use diuresis when clinically indicated.
TRALI During or within 6 hours of transfusion Acute hypoxemia, bilateral pulmonary edema, and no clear evidence that hydrostatic overload is the principal cause Stop transfusion, provide respiratory support, notify the transfusion service, and avoid reflexive diuresis unless overload is also present.
Hypotensive reaction Usually during transfusion Predominant hypotension without another established reaction Stop transfusion and exclude hemolysis, sepsis, anaphylaxis, TRALI, bleeding, and unrelated shock.

2. Acute hemolytic transfusion reaction

Acute hemolytic reactions may result from ABO incompatibility, another clinically significant RBC antibody, or less commonly nonimmune destruction. Clerical or identification errors must be considered immediately.

Suggested evaluation

  • Repeat patient and component identification checks
  • Visual inspection for plasma hemolysis
  • Repeat ABO/Rh typing and compatibility testing
  • Direct antiglobulin test
  • CBC and hemoglobin trend
  • LDH, bilirubin, haptoglobin, and plasma-free hemoglobin
  • Urinalysis for hemoglobinuria
  • Creatinine, electrolytes, and urine output
  • PT/INR, aPTT, fibrinogen, and D-dimer when DIC is possible
Fever or chills during transfusion should not automatically be called a febrile nonhemolytic reaction. Acute hemolysis and bacterial contamination must first be considered.

3. Allergic reaction versus anaphylaxis

Mild allergic reaction

  • Localized or generalized urticaria
  • Pruritus or flushing
  • No hypotension
  • No airway edema
  • No bronchospasm or respiratory compromise

Anaphylaxis

  • Hypotension or shock
  • Wheezing, bronchospasm, or stridor
  • Angioedema or airway compromise
  • Generalized symptoms affecting multiple systems
  • May occur after only a small infused volume

Treat anaphylaxis immediately

Intramuscular epinephrine is first-line treatment. Provide airway support, oxygen, IV fluids, and other resuscitative care as clinically required. Antihistamines do not replace epinephrine.

4. Suspected bacterial contamination

Platelets are particularly important to consider because they are stored at room temperature, although any blood component may be implicated.

Warning features

  • High fever or marked temperature increase
  • Severe rigors
  • Hypotension or shock
  • Nausea, vomiting, abdominal pain, or myalgias
  • DIC or acute kidney injury
  • Rapid clinical deterioration during transfusion

Immediate management

  • Stop the transfusion.
  • Notify the transfusion service urgently.
  • Obtain patient blood cultures.
  • Send the component and tubing for culture as directed.
  • Begin empiric broad-spectrum antimicrobial therapy promptly.
  • Provide sepsis and shock management.
Do not wait for cultures to become positive before treating a patient with a convincing septic transfusion reaction.

5. TACO versus TRALI

Feature TACO TRALI
Primary mechanism Hydrostatic pulmonary edema from circulatory overload Acute inflammatory lung injury with increased pulmonary capillary permeability
Blood pressure Hypertension is common, although hypotension may occur May be normal or low
Fluid balance Positive fluid balance or rapid/high-volume transfusion often supports the diagnosis Fluid overload is not the principal explanation
Cardiac findings Elevated filling pressures, JVD, cardiac dysfunction, or elevated natriuretic peptides may support TACO Left atrial hypertension should not be the primary cause of pulmonary edema
Diuresis Clinical improvement may support TACO Diuresis is not the primary treatment and may worsen hypotension
Chest imaging Bilateral pulmonary edema; cardiomegaly or pleural effusions may support overload Bilateral pulmonary edema compatible with acute lung injury
Treatment Oxygen, ventilatory support, diuresis when appropriate, and future transfusion-risk reduction Supportive respiratory care and transfusion-service investigation
TACO and TRALI can be difficult to distinguish, and some patients have mixed hydrostatic and inflammatory pulmonary edema. Do not force a false either-or diagnosis when evidence supports both processes.

Interactive tool

TACO versus TRALI bedside comparison

This tool organizes supportive findings. It does not replace formal hemovigilance definitions, echocardiography, laboratory testing, or transfusion-medicine review.

Select all five findings.

Report acute pulmonary reactions to the transfusion service even when the distinction remains uncertain.

6. Delayed transfusion reactions

Reaction Typical timing Clinical clues Priorities
Delayed hemolytic reaction Usually days to weeks Falling hemoglobin, jaundice, increased bilirubin or LDH, reduced haptoglobin, new antibody, or positive DAT Notify transfusion service, identify the antibody, assess hemolysis, and document it for future transfusions.
Delayed serologic reaction Days to weeks New antibody or DAT without clear clinical hemolysis Document the antibody and plan compatible future transfusions.
Post-transfusion purpura Commonly about 5–12 days Abrupt, severe thrombocytopenia with bleeding after transfusion Urgent hematology and transfusion-medicine consultation; IVIG is commonly used.
Transfusion-associated GVHD Usually 1–6 weeks Fever, rash, diarrhea, hepatitis, and progressive pancytopenia Urgent specialist evaluation. Prevention with appropriately irradiated cellular components is critical in at-risk patients.
Transfusion-transmitted infection Variable Depends on the organism; may present with fever, hepatitis, parasitemia, bacteremia, or other infection Notify transfusion service and infection prevention, obtain organism-specific testing, and treat appropriately.

Transfusion-associated GVHD warning pattern

Fever, rash, diarrhea, liver injury, and new pancytopenia within weeks of transfusion should prompt urgent consideration of transfusion-associated graft-versus-host disease.

7. Common transfusion-service investigation

The exact workup depends on the reaction and institutional policy. Common components include:

  • Clerical and bedside identification check
  • Visual inspection of pre- and post-transfusion plasma
  • Repeat ABO/Rh typing
  • Repeat compatibility testing
  • Direct antiglobulin test
  • Hemolysis laboratory studies
  • Patient blood cultures
  • Component culture
  • Chest imaging for respiratory reactions
  • BNP or NT-proBNP when TACO is being considered
  • Additional antibody investigation or eluate
Provide the transfusion service with the exact symptom onset, component type, volume infused, transfusion rate, vital-sign changes, fluid balance, medication exposure, and treatment response.

8. Can the transfusion be restarted?

Default rule: Do not restart a component implicated in a suspected serious reaction unless the patient has been evaluated and the transfusion service or institutional protocol explicitly permits it.

Do not restart when there is concern for

  • Acute hemolytic transfusion reaction
  • Bacterial contamination or septic reaction
  • Anaphylaxis
  • TRALI
  • TACO with ongoing respiratory compromise
  • Unexplained hypotension
  • Any severe or incompletely evaluated reaction

Some institutions permit cautious resumption after a strictly isolated mild allergic reaction once symptoms fully resolve and the patient has been reassessed. Follow the local transfusion-service decision rather than restarting independently.

9. Prevention of recurrent reactions

  • Document clinically significant RBC antibodies permanently in the transfusion record.
  • Use antigen-negative or appropriately matched RBCs when required.
  • Use slower transfusion rates, divided units, or volume reduction for selected patients at high risk of TACO.
  • Consider pretransfusion diuresis only when clinically appropriate; it does not eliminate TACO risk.
  • Use washed products for selected patients with recurrent severe allergic reactions under transfusion-medicine guidance.
  • Use irradiated cellular components for patients who meet accepted indications for prevention of transfusion-associated GVHD.
  • Follow specialized transfusion plans for sickle cell disease, thalassemia, IgA deficiency, platelet refractoriness, and prior severe reactions.

10. Resident summary

  1. Stop the transfusion whenever a clinically meaningful reaction is suspected.
  2. Stabilize the patient before waiting for the diagnostic workup.
  3. Recheck patient and component identification immediately.
  4. Notify the blood bank or transfusion service early.
  5. Fever requires exclusion of hemolysis and bacterial contamination before assuming a benign febrile reaction.
  6. Urticaria alone differs from anaphylaxis; hypotension or airway compromise requires epinephrine.
  7. TACO reflects circulatory overload; TRALI reflects acute inflammatory lung injury.
  8. Delayed hemolysis may present days to weeks later with an unexplained hemoglobin decline.
  9. Do not restart an implicated unit unless explicitly cleared under local policy.

11. Knowledge check

Question 1

A patient develops rigors and fever 15 minutes after a platelet transfusion begins. What is the first action?

Question 2

A patient develops wheezing, hypotension, generalized urticaria, and facial swelling shortly after plasma begins. What is the priority?

Question 3

Which finding most strongly supports TACO rather than TRALI?

Question 4

A patient’s hemoglobin unexpectedly falls 10 days after RBC transfusion. Bilirubin and LDH are elevated, and a new RBC antibody is detected. What is most likely?

Question 5

Which delayed syndrome is characterized by fever, rash, diarrhea, liver injury, and progressive pancytopenia after transfusion?

References

  1. Centers for Disease Control and Prevention. National Healthcare Safety Network Hemovigilance Module Protocol. 2026. CDC Hemovigilance
  2. AABB. Guide to the Laboratory Evaluation of Transfusion Reactions. AABB preview
  3. AABB. Association Bulletin: Transfusion-Associated Circulatory Overload. AABB bulletin
  4. AABB, ISBT and International Haemovigilance Network. Transfusion- associated circulatory overload surveillance definition. TACO definition
  5. Canadian Blood Services. Transfusion reactions. Clinical Guide to Transfusion. Clinical guide
  6. Canadian Blood Services. Transfusion-related acute lung injury. TRALI review
  7. International Society of Blood Transfusion. Adverse effects of transfusion. ISBT resource
  8. AABB, American Red Cross, America’s Blood Centers and Armed Services Blood Program. Circular of Information for the Use of Human Blood and Blood Components. Circular of Information

Educational disclaimer

This guide is intended for clinician education and does not replace institutional transfusion-reaction protocols, transfusion-service direction, emergency resuscitation standards, specialist consultation, or individualized clinical judgment. Major bleeding, anaphylaxis, hemolysis, sepsis, respiratory failure, and shock require immediate local escalation.